LZK-TARGETING DEGRADERS AND METHODS OF USE Read more about LZK-TARGETING DEGRADERS AND METHODS OF USE European Patent21790644.5Filed on 2023-03-29
LZK-TARGETING DEGRADERS AND METHODS OF USE Read more about LZK-TARGETING DEGRADERS AND METHODS OF USE US Application 18/176,849Filed on 2023-03-01
LZK-TARGETING DEGRADERS AND METHODS OF USE Read more about LZK-TARGETING DEGRADERS AND METHODS OF USE Australia2021336300Filed on 2023-02-15
LZK-TARGETING DEGRADERS AND METHODS OF USE Read more about LZK-TARGETING DEGRADERS AND METHODS OF USE Canada3193736Filed on 2023-03-02
LZK-TARGETING DEGRADERS AND METHODS OF USE Read more about LZK-TARGETING DEGRADERS AND METHODS OF USE Japan2023-513976Filed on 2023-02-28
CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF Read more about CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF Patent Cooperation TreatyPCT/US2023/062525Filed on 2023-02-14
AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENT Read more about AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENT US Application 18/012,260Filed on 2022-12-22
CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 European Patent20802725.0Filed on 2020-05-06
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION European Patent21752355.4Filed on 2023-02-10
HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation Read more about HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation US Application 18/015,781Filed on 2023-01-12